Clinical Services > Infection Control

Vehicle partition screens: the PPE for healthcare rides

22 December, 2020 by Megan Whelan*

Recent months have seen growing demand for partition screens in many countries to ensure extra precaution and mitigate the risks of coronavirus infection among drivers.


Isolation on demand, wherever you need it

17 December, 2020

Clinell Rediroom is an innovative alternative to increase the availability of additional isolation space to help prevent infections and save lives.


Oxford publishes peer-reviewed COVID-19 vaccine results

16 December, 2020

Interim results of the University of Oxford's COVID-19 vaccine Phase 3 trials find that the vaccine protects against symptomatic disease in 70% of cases on average.


Mobile CSSD provides flexible on-site capacity

15 December, 2020

A mobile or modular on-site sterilisation department can ensure continuity during periods of refurbishment or exceptional demand.


UK hospitals deploy Aus-designed pop-up patient isolation rooms

08 December, 2020

An instant patient isolation room that can be deployed in five minutes is being used by hospitals throughout the UK to isolate patients with COVID-19.


Research reveals gaps in adult pertussis vaccination

03 December, 2020

Older Australians may be missing out on protection against pertussis because GPs tend to focus on vaccinating those in close contact with young children.


How long until the leading vaccines make it to market?

02 December, 2020 by Amy Sarcevic

Pfizer and BioNTech may face major hurdles in getting their vaccine to market, despite recently being touted as winners of the COVID-19 vaccine race.


Research reveals likely locations of next pandemic

27 November, 2020

An international team of human and animal health experts has identified areas at risk of harbouring the conditions that may lead to the next pandemic.


AstraZeneca vaccine candidate

26 November, 2020 by Nicholas Wood, University of Sydney for The Conversation

AstraZeneca's results signal more good vaccine news — but efficacy is only the beginning of the story.


Monash superbug project to mobilise genomics, digital health and AI

23 November, 2020

The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system.


Interim results: Moderna vaccine candidate stable and effective

20 November, 2020

Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.


Drug-resistant UTIs: the canary in the coalmine

19 November, 2020

One of the world's most common infections will cost Australia more than $1 billion a year within the next decade if nothing is done to stop the rise of antibiotic-resistant bacteria.


How did Royal Melbourne Hospital curb its COVID-19 outbreak?

16 November, 2020

Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined.


Vaccinate potential superspreaders first, researchers say

13 November, 2020

Macquarie University researchers have unveiled a strategy that models who should be vaccinated first.


Australian experts respond to Pfizer vaccine announcement

12 November, 2020

Pfizer and BioNTech have issued a press release, announcing that their vaccine candidate is more than 90% effective in preventing COVID-19.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd